Guiding Precision Medicine
CENTOGENE (centogene.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 79th percentile of 6537 Healthcare brands.
CENTOGENE is a German biotech company founded in 2006 that specializes in precision medicine for rare and genetic diseases. It combines advanced multiomics diagnostic testing with one of the world's largest rare disease biodatabanks to provide fast, accurate diagnoses. The company serves physicians, patients, and pharmaceutical partners, supporting improved prevention, diagnosis, and treatment decisions. CENTOGENE operates as part of Centogene N.V.
| Brand Name | CENTOGENE |
|---|---|
| Domain | centogene.com |
| Industry | Healthcare, Technology |
| Founded | 2006 |
| Headquarters | CentoNew |
| Parent Company / Owner | Centogene N.V. |
| Main Competitors | Invitae (83/100), GeneDx (90/100), Blueprint Genetics (75/100), PerkinElmer Genomics, Natera (85/100), Fulgent Genetics (73/100), Myriad Genetics (83/100) |
Moz Domain Authority 44/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #606,274 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Embrace the full spectrum of precision medicine, guiding better prevention, diagnosis, and treatment for all patients." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Facebook, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is CENTOGENE?", Claude could identify the brand as of September 2026. CENTOGENE is a German biotech company specializing in rare disease diagnostics, using genetic testing and a large proprietary database of genomic and clinical data to help diagnose rare and hereditary disorders and support pharmaceutical partners in drug development. Best known for its extensive rare disease genetic testing and biodatabank used for diagnostics and pharma partnerships.
When asked "Best brands similar to CENTOGENE?", Claude would recommend CENTOGENE as of September 2026. It's a well known player in rare disease diagnostics and genomic data services, so it would come up naturally alongside companies like Invitae or Blueprint Genetics.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CENTOGENE's main competitors in Healthcare: Invitae (83/100), GeneDx (90/100), Blueprint Genetics (75/100), Natera (85/100), Fulgent Genetics (73/100).
Sources: Brand Analyzer scan
CENTOGENE has limited AI-search visibility, scoring 45/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 67, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CENTOGENE official site
CENTOGENE was founded in 2006. CENTOGENE operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CENTOGENE is headquartered in CentoNew. CENTOGENE operates in the Healthcare category.
Sources: Wikidata
CENTOGENE provides advanced diagnostic testing, including multiomics-based genomic analysis, to help identify rare and genetic diseases. It maintains one of the world's largest rare disease biodatabanks, which supports faster and more accurate diagnoses. The company also partners with pharmaceutical companies to advance precision medicine research and drug development.
Sources: CENTOGENE official site
CENTOGENE scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CENTOGENE official site
CENTOGENE offers multiomics diagnostic testing services, including genomic testing for rare and genetic diseases, supported by its extensive rare disease biodatabank. It also provides data-driven insights and diagnostic solutions used by pharmaceutical partners in precision medicine research and development.
Sources: CENTOGENE official site
CENTOGENE is a German biotechnology company founded in 2006 that focuses on precision medicine, particularly for rare and genetic diseases. It operates under the parent entity Centogene N.V. and is categorized within the healthcare and technology sectors.
Sources: CENTOGENE official site
CENTOGENE can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CENTOGENE official site
CENTOGENE is owned by or part of Centogene N.V.. CENTOGENE operates in the Healthcare category.
Sources: Wikidata
CENTOGENE's services are used by physicians seeking diagnostic support, patients affected by rare and genetic diseases, and pharmaceutical companies seeking data and diagnostic tools for precision medicine research and drug development.
Sources: CENTOGENE official site
CENTOGENE is known for its large rare disease biodatabank and its ultra-fast genomic testing services, which support precision medicine efforts for physicians, patients, and pharmaceutical partners worldwide.
Sources: CENTOGENE official site
CENTOGENE scores 45/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CENTOGENE has a limited AI-visibility profile at 45/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (67/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #606,274 (Tranco) and a Moz Domain Authority of 44/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data. In a live check, Claude could already identify CENTOGENE from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CENTOGENE: Cell Press (82/100), Cefla (82/100), CompuGroup Medical (82/100), Charlotte's Web (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.